VIR BIOTECHNOLOGY, United States
Disclosure information not submitted.
How a potent anti-neuraminidase monoclonal antibody navigates recent immune-evasive influenza strains: A structural study by single-particle cryoEM
Wednesday, July 26, 202311:30 AM – 11:45 AM US CST